Annals of Oncology

Acknowledgements:

Acknowledgements
Ann Oncol 16: v7; doi:10.1093/annonc/mdi596 [PDF]

Summary of Conference Schedule:

Summary of Conference Schedule
Ann Oncol 16: v9-v11; doi:10.1093/annonc/mdi598 [PDF]

Satellite Symposia Schedule:

Satellite Symposia Schedule
Ann Oncol 16: v13-v14; doi:10.1093/annonc/mdi597 [PDF]

Conference Schedule:

Conference Schedule
Ann Oncol 16: v15-v26; doi:10.1093/annonc/mdi599 [PDF]

Abstracts:

Henry Kaplan Memorial Lecture
Ann Oncol 16: v27; doi:10.1093/annonc/mdi540 [PDF]

Oral Presentations:

1. Virology, Epidemiology
Ann Oncol 16: v28-v29; doi:10.1093/annonc/mdi541 [PDF]

2. Multiple Myleoma
Ann Oncol 16: v30-v31; doi:10.1093/annonc/mdi542 [PDF]

3. What is the Role of High Dose Chemotherapy for Follicular Lymphoma?
Ann Oncol 16: v32; doi:10.1093/annonc/mdi543 [PDF]

4. Immunotherapy
Ann Oncol 16: v33-v34; doi:10.1093/annonc/mdi544 [PDF]

5. Biology of Lymphomas I
Ann Oncol 16: v35; doi:10.1093/annonc/mdi545 [PDF]

6. Biology of Lymphomas II
Ann Oncol 16: v36-v38; doi:10.1093/annonc/mdi546 [PDF]

7. Henry Rappaport Memorial Lecture
Ann Oncol 16: v39; doi:10.1093/annonc/mdi547 [PDF]

8. Review Lectures on Hodgkin's Disease
Ann Oncol 16: v40-v41; doi:10.1093/annonc/mdi548 [PDF]

9. Chronic Lymphocytic Leukaemia
Ann Oncol 16: v42-v44; doi:10.1093/annonc/mdi549 [PDF]

10. Is R-CHOP the Standard Treatment for DLCL?
Ann Oncol 16: v45; doi:10.1093/annonc/mdi550 [PDF]

11. 10 Years WHO Classification
Ann Oncol 16: v46-v47; doi:10.1093/annonc/mdi551 [PDF]

12. Mantle Cell Lymphoma
Ann Oncol 16: v48-v49; doi:10.1093/annonc/mdi552 [PDF]

13. John Ultmann Memorial Lecture
Ann Oncol 16: v50; doi:10.1093/annonc/mdi553 [PDF]

14. Clinical Results in Lymphoma I
Ann Oncol 16: v51-v53; doi:10.1093/annonc/mdi554 [PDF]

15. Clinical Results in Lymphoma II
Ann Oncol 16: v54-v57; doi:10.1093/annonc/mdi555 [PDF]

16. Clinical-Pathological Correlations
Ann Oncol 16: v58-v60; doi:10.1093/annonc/mdi556 [PDF]

17. Paediatric Lymphomas
Ann Oncol 16: v61-v63; doi:10.1093/annonc/mdi557 [PDF]

18. Lymphoma Transformation
Ann Oncol 16: v64; doi:10.1093/annonc/mdi558 [PDF]

19. New Agents
Ann Oncol 16: v65-v67; doi:10.1093/annonc/mdi559 [PDF]

20. New Treatment Modalities
Ann Oncol 16: v68-v69; doi:10.1093/annonc/mdi560 [PDF]

21. New Immunological Principles
Ann Oncol 16: v70-v72; doi:10.1093/annonc/mdi561 [PDF]

Posters:

1. Biology/Genetics/Immunology
Ann Oncol 16: v73-v82; doi:10.1093/annonc/mdi562 [PDF]

2. Biology of Hodgkin's Disease
Ann Oncol 16: v83-v85; doi:10.1093/annonc/mdi563 [PDF]

3. CLL/Multiple Myeloma
Ann Oncol 16: v86-v91; doi:10.1093/annonc/mdi564 [PDF]

4. Extranodal Lymphomas I
Ann Oncol 16: v92-v94; doi:10.1093/annonc/mdi565 [PDF]

5. Aggressive Lymphomas
Ann Oncol 16: v95-v104; doi:10.1093/annonc/mdi566 [PDF]

6. Indolent Lymphomas
Ann Oncol 16: v105-v113; doi:10.1093/annonc/mdi567 [PDF]

7. Hodgkin's Disease
Ann Oncol 16: v114-v119; doi:10.1093/annonc/mdi568 [PDF]

8. Role of PET
Ann Oncol 16: v120-v122; doi:10.1093/annonc/mdi569 [PDF]

9. Extranodal Lymphomas II
Ann Oncol 16: v123-v126; doi:10.1093/annonc/mdi570 [PDF]

10. T-cell Lymphoma/HIV-Lymphoma
Ann Oncol 16: v127-v132; doi:10.1093/annonc/mdi571 [PDF]

11. Pediatric Lymphomas
Ann Oncol 16: v133; doi:10.1093/annonc/mdi572 [PDF]

12. New Treatments
Ann Oncol 16: v134-v137; doi:10.1093/annonc/mdi573 [PDF]

Further Abstracts:

1. Virology/Epidemiology
Ann Oncol 16: v138-v139; doi:10.1093/annonc/mdi574 [PDF]

2. Biology/Genetics
Ann Oncol 16: v140-v144; doi:10.1093/annonc/mdi575 [PDF]

3. Imaging
Ann Oncol 16: v145-v147; doi:10.1093/annonc/mdi576 [PDF]

4. Indolent Lymphomas
Ann Oncol 16: v148-v158; doi:10.1093/annonc/mdi577 [PDF]

5. Extranodal Lymphomas
Ann Oncol 16: v159-v167; doi:10.1093/annonc/mdi578 [PDF]

6. Mantle Cell Lymphomas
Ann Oncol 16: v168-v171; doi:10.1093/annonc/mdi579 [PDF]

7. Diffuse Large Cell Lymphomas (DLCL)
Ann Oncol 16: v172-v186; doi:10.1093/annonc/mdi580 [PDF]

8. T-cell Lymphomas/Lymphomas in AIDS
Ann Oncol 16: v187-v190; doi:10.1093/annonc/mdi581 [PDF]

9. Hodgkin's Disease
Ann Oncol 16: v191-v199; doi:10.1093/annonc/mdi582 [PDF]

10. CLL/Multiple Myeloma
Ann Oncol 16: v200-v206; doi:10.1093/annonc/mdi583 [PDF]

11.New treatments/New drugs
Ann Oncol 16: v207-v211; doi:10.1093/annonc/mdi584 [PDF]

12. Pediatric Lymphomas
Ann Oncol 16: v212-v213; doi:10.1093/annonc/mdi585 [PDF]

13. Miscellaneous
Ann Oncol 16: v214-v220; doi:10.1093/annonc/mdi586 [PDF]

Author Index:

AUTHOR INDEX
Ann Oncol 16: v221-v235; doi:10.1093/annonc/mdi538 [PDF] [Erratum to author index]

Subject Index:

SUBJECT INDEX
Ann Oncol 16: v237-v242; doi:10.1093/annonc/mdi537 [PDF]

Schedules and Abstracts of Satellite Symposia:

Schedules and Abstracts of Satellite Symposium
Ann Oncol 16: v243-v245; doi:10.1093/annonc/mdi587 [PDF]

ADVANCES IN OUR UNDERSTANDING OF CUTANEOUS T-CELL LYMPHOMAS: NOVEL THERAPEUTIC APPROACHES
Ann Oncol 16: v246-v248; doi:10.1093/annonc/mdi588 [PDF]

NEORECORMON^® - JUST FOR ANAEMIA?
Ann Oncol 16: v249-v250; doi:10.1093/annonc/mdi589 [PDF]

ZEVALIN^®: TARGETING FOR CURE IN NHL
Ann Oncol 16: v251-v252; doi:10.1093/annonc/mdi590 [PDF]

NEW APPROACHES IN RELAPSING MALIGNANT LYMPHOMA
Ann Oncol 16: v253-v254; doi:10.1093/annonc/mdi591 [PDF]

MABCAMPATH^®: INCREASING SURVIVAL IN CLL
Ann Oncol 16: v255-v256; doi:10.1093/annonc/mdi592 [PDF]

NOVEL USES OF PENTOSTATIN FOR LYMPHOID MALIGNANCIES
Ann Oncol 16: v257-v258; doi:10.1093/annonc/mdi593 [PDF]

INNOVATIVE TREATMENT OPTIONS FOR INDOLENT LYMPHOMAS
Ann Oncol 16: v259-v260; doi:10.1093/annonc/mdi594 [PDF]

ADVANCES IN BIOLOGY AND THERAPY OF WALDENSTRÖM'S MACROGLOBULINEMIA
Ann Oncol 16: v261-v262; doi:10.1093/annonc/mdi595 [PDF]

To see an article, click its [Full Text] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.